Company intelligence / Profile preview

OptimizeRx

Rochester, Michigan, United Statesoptimizerx.com ↗

Ownership: Public · OPRX
Development stage: Commercial

Overview

OptimizeRx delivers an AI-driven healthcare marketing and communications platform that connects pharmaceutical brands with healthcare providers (HCPs) and patients at critical points in care. Their DAAP solution leverages real-world data to deliver targeted messaging, support patient affordability programs, and improve treatment awareness within EHR/ePrescribing workflows. The company reports measurable improvements in script lift and audience quality for clients but does not conduct clinical trials or have clinical results in the traditional biotech sense.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

EHR/ePrescribe platforms (unnamed)Health IT companies (unnamed)

Financials

Market cap: $134.5M
Total revenue: $20.5M
Enterprise value: $129.9M

Beyond the preview

Go deeper on OptimizeRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OptimizeRx.

Explore the full profile